Sarcopenia Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1062743
  • May 2021
  • Pharmaceuticals
  • 115 Pages
The Sarcopenia Treatment market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Sarcopenia Treatment market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Abbott Laboratories, Bayer AG, Cadila Healthcare Ltd., Eli Lilly and Company, GlaxoSmithKline Plc.,, Nestlé S.A.,, Novartis AG, Pfizer Inc.,, Radius Health, Inc., Sanofi S.A.,
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Sarcopenia Treatment market along with their effects over the forecast period. Similarly, according to the region Sarcopenia Treatment market research report includes the study of opportunities available in the market situation.

The Sarcopenia Treatment market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Sarcopenia Treatment Market:
The Sarcopenia Treatment market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Abbott Laboratories, Bayer AG, Cadila Healthcare Ltd., Eli Lilly and Company, GlaxoSmithKline Plc.,, Nestlé S.A.,, Novartis AG, Pfizer Inc.,, Radius Health, Inc., Sanofi S.A.,

Sarcopenia Treatment Market Segmentation Analysis:
by Treatment Type
Protein Supplement
Vitamin B12 Supplement
Vitamin D and Calcium Supplement
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies Hypermarket and Supermarket

Global Sarcopenia Treatment Market Segmentation by Regions:
In regional analysis, Sarcopenia Treatment market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Sarcopenia Treatment market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Sarcopenia Treatment Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Sarcopenia Treatment Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Sarcopenia Treatment Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Sarcopenia Treatment Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Sarcopenia Treatment Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Sarcopenia Treatment market, according to the key region.
  • To study the Sarcopenia Treatment market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Sarcopenia Treatment market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Sarcopenia Treatment research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Sarcopenia Treatment market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Sarcopenia Treatment market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Sarcopenia Treatment market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Sarcopenia Treatment market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Sarcopenia Treatment market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Abbott Laboratories
  • Bayer AG
  • Cadila Healthcare Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline Plc.,
  • Nestlé S.A.,
  • Novartis AG
  • Pfizer Inc.,
  • Radius Health, Inc.
  • Sanofi S.A.,
  • Protein Supplement
  • Vitamin B12 Supplement
  • Vitamin D and Calcium Supplement
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies Hypermarket and Supermarket

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Sarcopenia Treatment Market Snapshot
          2.1.1. Global Sarcopenia Treatment Market By Treatment Type,2019
               2.1.1.1.Protein Supplement
               2.1.1.2.Vitamin B12 Supplement
               2.1.1.3.Vitamin D and Calcium Supplement
          2.1.2. Global Sarcopenia Treatment Market By Distribution Channel,2019
               2.1.2.1.Hospital Pharmacies
               2.1.2.2.Retail Pharmacies
               2.1.2.3.Online Pharmacies Hypermarket and Supermarket
          2.1.3. Global Sarcopenia Treatment Market By End-use,2019
          2.1.4. Global Sarcopenia Treatment Market By Geography,2019

3. Global Sarcopenia Treatment Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Sarcopenia Treatment Market Size (US$), By Treatment Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Treatment Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Treatment Type, 2020
     4.2. Global Sarcopenia Treatment Market Size (US$), By Treatment Type, 2018 – 2028

5. Global Sarcopenia Treatment Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Sarcopenia Treatment Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Sarcopenia Treatment Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Sarcopenia Treatment Market Size (US$), By End-use, 2018 – 2028

7. Global Sarcopenia Treatment Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Sarcopenia Treatment Market Analysis, 2018 – 2028 
          7.2.1. North America Sarcopenia Treatment Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Sarcopenia Treatment Market Size (US$), By Treatment Type, 2018 – 2028
          7.2.3. North America Sarcopenia Treatment Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Sarcopenia Treatment Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Sarcopenia Treatment Market Analysis, 2018 – 2028 
          7.3.1.  Europe Sarcopenia Treatment Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Sarcopenia Treatment Market Size (US$), By Treatment Type, 2018 – 2028
          7.3.3. Europe Sarcopenia Treatment Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Sarcopenia Treatment Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Sarcopenia Treatment Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Sarcopenia Treatment Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Sarcopenia Treatment Market Size (US$), By Treatment Type, 2018 – 2028
          7.4.3. Asia Pacific Sarcopenia Treatment Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Sarcopenia Treatment Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Sarcopenia Treatment Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Sarcopenia Treatment Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Sarcopenia Treatment Market Size (US$), By Treatment Type, 2018 – 2028
          7.5.3. Latin America Sarcopenia Treatment Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Sarcopenia Treatment Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Sarcopenia Treatment Market Analysis, 2018 – 2028 
          7.6.1.  MEA Sarcopenia Treatment Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Sarcopenia Treatment Market Size (US$), By Treatment Type, 2018 – 2028
          7.6.3. MEA Sarcopenia Treatment Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Sarcopenia Treatment Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Sarcopenia Treatment Providers
        8.4.1 Abbott Laboratories
                8.4.1.1 Business Description
                8.4.1.2 Abbott Laboratories Geographic Operations
                8.4.1.3 Abbott Laboratories Financial Information
                8.4.1.4 Abbott Laboratories Product Positions/Portfolio
                8.4.1.5 Abbott Laboratories Key Developments
        8.4.2 Bayer AG
                8.4.2.1 Business Description
                8.4.2.2 Bayer AG Geographic Operations
                8.4.2.3 Bayer AG Financial Information
                8.4.2.4 Bayer AG Product Positions/Portfolio
                8.4.2.5 Bayer AG Key Developments
        8.4.3 Cadila Healthcare Ltd.
                8.4.3.1 Business Description
                8.4.3.2 Cadila Healthcare Ltd. Geographic Operations
                8.4.3.3 Cadila Healthcare Ltd. Financial Information
                8.4.3.4 Cadila Healthcare Ltd. Product Positions/Portfolio
                8.4.3.5 Cadila Healthcare Ltd. Key Developments
        8.4.4 Eli Lilly and Company
                8.4.4.1 Business Description
                8.4.4.2 Eli Lilly and Company Geographic Operations
                8.4.4.3 Eli Lilly and Company Financial Information
                8.4.4.4 Eli Lilly and Company Product Positions/Portfolio
                8.4.4.5 Eli Lilly and Company Key Developments
        8.4.5 GlaxoSmithKline Plc.,
                8.4.5.1 Business Description
                8.4.5.2 GlaxoSmithKline Plc., Geographic Operations
                8.4.5.3 GlaxoSmithKline Plc., Financial Information
                8.4.5.4 GlaxoSmithKline Plc., Product Positions/Portfolio
                8.4.5.5 GlaxoSmithKline Plc., Key Developments
        8.4.6 Nestlé S.A.,
                8.4.6.1 Business Description
                8.4.6.2 Nestlé S.A., Geographic Operations
                8.4.6.3 Nestlé S.A., Financial Information
                8.4.6.4 Nestlé S.A., Product Positions/Portfolio
                8.4.6.5 Nestlé S.A., Key Developments
        8.4.7 Novartis AG
                8.4.7.1 Business Description
                8.4.7.2 Novartis AG Geographic Operations
                8.4.7.3 Novartis AG Financial Information
                8.4.7.4 Novartis AG Product Positions/Portfolio
                8.4.7.5 Novartis AG Key Developments
        8.4.8 Pfizer Inc.,
                8.4.8.1 Business Description
                8.4.8.2 Pfizer Inc., Geographic Operations
                8.4.8.3 Pfizer Inc., Financial Information
                8.4.8.4 Pfizer Inc., Product Positions/Portfolio
                8.4.8.5 Pfizer Inc., Key Developments
        8.4.9 Radius Health, Inc.
                8.4.9.1 Business Description
                8.4.9.2 Radius Health, Inc. Geographic Operations
                8.4.9.3 Radius Health, Inc. Financial Information
                8.4.9.4 Radius Health, Inc. Product Positions/Portfolio
                8.4.9.5 Radius Health, Inc. Key Developments
        8.4.10 Sanofi S.A.,
                8.4.10.1 Business Description
                8.4.10.2 Sanofi S.A., Geographic Operations
                8.4.10.3 Sanofi S.A., Financial Information
                8.4.10.4 Sanofi S.A., Product Positions/Portfolio
                8.4.10.5 Sanofi S.A., Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Sarcopenia Treatment Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Sarcopenia Treatment Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Sarcopenia Treatment Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Sarcopenia Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Sarcopenia Treatment Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Sarcopenia Treatment Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Sarcopenia Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Sarcopenia Treatment Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Sarcopenia Treatment Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Sarcopenia Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Sarcopenia Treatment Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Sarcopenia Treatment Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Sarcopenia Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Sarcopenia Treatment Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Sarcopenia Treatment Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Sarcopenia Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Sarcopenia Treatment: Market Segmentation 
FIG. 2 Global Sarcopenia Treatment Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Sarcopenia Treatment Market, By Treatment Type, 2019 (US$ Mn) 
FIG. 5 Global Sarcopenia Treatment Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Sarcopenia Treatment Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Sarcopenia Treatment Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Sarcopenia Treatment Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Sarcopenia Treatment Providers, 2019
FIG. 11 Global Sarcopenia Treatment Market Revenue Contribution, By Treatment Type, 2019 & 2028 (Value %) 
FIG. 12 Global Sarcopenia Treatment Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Sarcopenia Treatment Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Sarcopenia Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Sarcopenia Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Sarcopenia Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Sarcopenia Treatment Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Sarcopenia Treatment Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Sarcopenia Treatment market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Sarcopenia Treatment Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Sarcopenia Treatment Market Value, By Segment1, 2018 – 2028
TABLE  North America Sarcopenia Treatment Market Value, By Segment2, 2018 – 2028
TABLE  North America Sarcopenia Treatment Market Value, By Country, 2018 – 2028
TABLE  Europe Sarcopenia Treatment Market Value, By Segment1, 2018 – 2028
TABLE  Europe Sarcopenia Treatment Market Value, By Segment2, 2018 – 2028
TABLE  Europe Sarcopenia Treatment Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Sarcopenia Treatment Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Sarcopenia Treatment Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Sarcopenia Treatment Market Value, By Country, 2018 – 2028
TABLE  Latin America Sarcopenia Treatment Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Sarcopenia Treatment Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Sarcopenia Treatment Market Value, By Country, 2018 – 2028
TABLE  MEA Sarcopenia Treatment Market Value, By Segment1, 2018 – 2028
TABLE  MEA Sarcopenia Treatment Market Value, By Segment2, 2018 – 2028
TABLE  MEA Sarcopenia Treatment Market Value, By Country, 2018 – 2028
TABLE  Abbott Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bayer AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cadila Healthcare Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly and Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline Plc.,: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Nestlé S.A.,: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.,: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Radius Health, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi S.A.,: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Sarcopenia Treatment Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Sarcopenia Treatment Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Sarcopenia Treatment Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Sarcopenia Treatment Market, By Geography, 2019 (US$ Mn)
FIG.  Global Sarcopenia Treatment Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Sarcopenia Treatment Providers, 2016
FIG.  Global Sarcopenia Treatment Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Vitamin B12 Supplement Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Vitamin D and Calcium Supplement Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Sarcopenia Treatment Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Online Pharmacies Hypermarket and Supermarket Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Sarcopenia Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Sarcopenia Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Sarcopenia Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Sarcopenia Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Sarcopenia Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Sarcopenia Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Sarcopenia Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Sarcopenia Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Sarcopenia Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Sarcopenia Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Sarcopenia Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Sarcopenia Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Sarcopenia Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Sarcopenia Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Sarcopenia Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Sarcopenia Treatment Market Value, 2018 – 2028, (US$ Mn)